CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 89 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,984,927 | +4155.4% | 77,692 | +2464.1% | 0.02% | – |
| Q1 2023 | $70,145 | -91.6% | 3,030 | -90.5% | 0.00% | -100.0% |
| Q4 2022 | $835,466 | -28.6% | 31,888 | -46.4% | 0.01% | -28.6% |
| Q3 2022 | $1,170,000 | -58.2% | 59,501 | -62.8% | 0.01% | -58.8% |
| Q2 2022 | $2,799,000 | +10266.7% | 160,059 | +9600.5% | 0.02% | – |
| Q1 2022 | $27,000 | -97.1% | 1,650 | -97.1% | 0.00% | -100.0% |
| Q4 2021 | $937,000 | +3246.4% | 57,451 | +2785.5% | 0.01% | – |
| Q2 2021 | $28,000 | +366.7% | 1,991 | +425.3% | 0.00% | – |
| Q4 2020 | $6,000 | – | 379 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |